operates as a molecular diagnostics company in the United States.
It engages in the development and marketing of molecular diagnostic solutions for various deoxyribonucleic acid and ribonucleic acid analysis applications, providing clinicians and researchers with molecular solutions.
Its products include analyte specific reagents that allow laboratories to create assays to perform hepatitis C virus genotyping, to screen for cystic fibrosis and other inherited disorders, and to test for the Factor V Leiden, and a host of other mutations associated with predisposition to cardiovascular and other diseases.
The company’s products provide clinicians and researchers with solutions for diagnosis and treatment of disease.
The company’s molecular diagnostic products are used by clinical testing laboratories that perform prognostic, diagnostic, and monitoring testing.
Third Wave Technologies was founded by Lance Fors in 1993.
The company is headquartered in Madison, Wisconsin.
